Cargando…
Genetics and biology of pancreatic ductal adenocarcinoma
With 5-year survival rates remaining constant at 6% and rising incidences associated with an epidemic in obesity and metabolic syndrome, pancreatic ductal adenocarcinoma (PDAC) is on track to become the second most common cause of cancer-related deaths by 2030. The high mortality rate of PDAC stems...
Autores principales: | Ying, Haoqiang, Dey, Prasenjit, Yao, Wantong, Kimmelman, Alec C., Draetta, Giulio F., Maitra, Anirban, DePinho, Ronald A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762423/ https://www.ncbi.nlm.nih.gov/pubmed/26883357 http://dx.doi.org/10.1101/gad.275776.115 |
Ejemplares similares
-
Recent insights into the biology of pancreatic cancer
por: Yao, Wantong, et al.
Publicado: (2020) -
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
por: Kelly, Kimberly A, et al.
Publicado: (2008) -
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011) -
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma
por: Ju, Huai-Qiang, et al.
Publicado: (2017) -
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
por: Kang, Ya’an, et al.
Publicado: (2022)